Active Biotech Total Debt vs. Price To Earning
| ACTI Stock | SEK 0.12 0.01 9.09% |
For Active Biotech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Active Biotech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Active Biotech AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Active Biotech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Active Biotech AB over time as well as its relative position and ranking within its peers.
Active |
Active Biotech AB Price To Earning vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Active Biotech's current stock value. Our valuation model uses many indicators to compare Active Biotech value to that of its competitors to determine the firm's financial worth. Active Biotech AB is rated fifth in total debt category among its peers. It is number one stock in price to earning category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Active Biotech's earnings, one of the primary drivers of an investment's value.Active Total Debt vs. Competition
Active Biotech AB is rated fifth in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 9.57 Billion. Active Biotech adds roughly 200,000 in total debt claiming only tiny portion of equities under Health Care industry.
Active Price To Earning vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Active Biotech |
| = | 200 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Active Biotech |
| = | (8.47) X |
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Active Price To Earning Comparison
Active Biotech is currently under evaluation in price to earning category among its peers.
Active Biotech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Active Biotech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Active Biotech will eventually generate negative long term returns. The profitability progress is the general direction of Active Biotech's change in net profit over the period of time. It can combine multiple indicators of Active Biotech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Active Biotech AB , a biotechnology company, develops drugs for the treatment of neurodegenerative diseases, autoimmunityinflammatory, and cancer. Active Biotech AB was incorporated in 1982 and is based in Lund, Sweden. Active Biotech operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 12 people.
Active Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Active Biotech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Active Biotech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Active Biotech's important profitability drivers and their relationship over time.
Use Active Biotech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Active Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Active Biotech will appreciate offsetting losses from the drop in the long position's value.Active Biotech Pair Trading
Active Biotech AB Pair Trading Analysis
The ability to find closely correlated positions to Active Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Active Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Active Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Active Biotech AB to buy it.
The correlation of Active Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Active Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Active Biotech AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Active Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Active Biotech position
In addition to having Active Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Banking Thematic Idea Now
Banking
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Banking theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banking Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Active Stock Analysis
When running Active Biotech's price analysis, check to measure Active Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Active Biotech is operating at the current time. Most of Active Biotech's value examination focuses on studying past and present price action to predict the probability of Active Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Active Biotech's price. Additionally, you may evaluate how the addition of Active Biotech to your portfolios can decrease your overall portfolio volatility.